Allocord (HPC, Cord Blood)

Allocord (HPC, Cord Blood) is an allogeneic cord blood hematopoietic progenitor cell therapy that uses stem cells from donated umbilical cord blood to help rebuild the blood and immune systems. It is used for patients who need a stem cell transplant because their blood or immune systems have been damaged by disease, inherited disorders, or aggressive treatments like chemotherapy.

The decision to use Allocord for a specific patient depends on several factors, such as the patient’s disease type and severity, the risks involved, the quality of the donor cells, and other available treatment options.

Recommended Dosage: The minimum recommended dose of Allocord (HPC, Cord Blood) is 2.5 x 10^7 nucleated cells per kg at cryopreservation. It is for intravenous use only. Multiple units may be required to achieve the appropriate dose. Matching for a minimum of 4 of 6 HLA-A antigens, HLA-B antigens, and HLA-DRB1 alleles is recommended. The HLA typing and nucleated cell content for each unit of Allocord (HPC, Cord Blood) are documented in accompanying records.

• Allocord can cause allergic reactions, including severe anaphylaxis. Monitor patients for signs of hypersensitivity during and after infusion, such as rash, itching, or difficulty breathing. Be prepared to provide appropriate medical treatment immediately if such reactions occur.
  
• Patients may experience infusion-related reactions, such as fever, chills, or nausea. To reduce the risk, pre-medicate patients with antihistamines, steroids, or antipyretics before administering Allocord. Monitor vital signs closely during the infusion.
  
• GVHD is a potential complication where donor cells attack the recipient’s body. It can affect the skin, liver, and gastrointestinal tract. Carefully monitor patients for symptoms and provide prompt treatment if GVHD is suspected.
  
• Engraftment syndrome may present with fever, rash, and weight gain. Early recognition and management are essential. Administer corticosteroids if necessary.
  
• There is a risk of graft failure, where donor cells do not adequately populate the recipient’s bone marrow. Monitor blood counts and be prepared for additional interventions, including repeat transplantation if needed.
  
• There is a possibility of donor-origin malignancies. Regular follow-up and monitoring are advised to detect any signs of malignancy early.
  
• Rare genetic disorders may be transmitted from donor to recipient. Genetic counseling and thorough donor screening are recommended to mitigate these risks.
  
• Allocord may carry a risk of transmitting infections. Ensure rigorous screening and testing procedures to minimize this risk.
  

What documents are required to import ALLOCORD to India?

ALLOCORD (HPC, Cord Blood) can be imported by patients or government hospitals only in the patients’ name. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

ALLOCORD (HPC, Cord Blood) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Allocord (HPC, Cord Blood) in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of ALLOCORD (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Allocord (HPC, Cord Blood) price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the ALLOCORD (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Allocord®?

Hematopoietic Progenitor Cell, Cord Blood is a Generic Name for the trade name drug Allocord®.

What is the Manufacturer’s Name of Allocord®?

Allocord® is manufactured by SSM Cardinal Glennon Children’s Medical Center.

Is Allocord® approved by the FDA?

Yes, Allocord® is approved by the FDA. Date of first approval: May 30, 2013.

What is the dosage and form of Allocord® supplied?

Allocord® is supplied as a cryopreserved cell suspension in a sealed bag containing a minimum of 5

x 108 total nucleated cells with a minimum of 1.25 x 106 viable CD34+ cells in a volume of 35

milliliters for IV use. 

What are the most common side effects of Allocord® (HPC, Cord Blood)? 

The most common infusion-related side effects of Allocord® are vomiting, nausea, hypertension, bradycardia, and fever.

How much does Allocord® (HPC, Cord Blood) cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Allocord (HPC, Cord Blood) in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Allocord® (HPC, Cord Blood) be available in SAARC countries? 

Apart from Gulf countries, Allocord can be available in SAARC countries (India, Afghanistan, Bangladesh, Bhutan, Maldives, Nepal, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Allocord in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

What are the storage conditions of Allocord® (HPC, Cord Blood)?

Store Allocord® (HPC, Cord Blood) at or below -150 °C until ready for thawing and preparation.